MassIVE MSV000087019

Partial Public

Similarities and differences in the structures and proteoform profiles of the Complement proteins C6 and C7

Description

In this study, we used an integrative structural MS-based approach combining native MS, glycopeptide-centric MS, in-gel cross-linking MS (IGX-MS) to describe structural and glycosylation features of soluble C7. We compare this data with structural and glycosylation data for C6. For native MS analysis, proteins were buffer-exchanged into 150 mM aqueous ammonium acetate (pH 7.5) and analyzed on a modified Q-Exactive Plus Orbitrap mass spectrometer with extended mass range (EMR). For glyco-peptide centric analysis LC-MS and MS/MS analysis, C6 and C7 were digested by trypsin and a combination of Glu-C and trypsin. The resulting peptide mixtures were desalted, dried, and reconstituted in formic acid before MS analysis. All peptides were separated and analyzed using an Agilent 1290 Infinity HPLC system coupled on-line to an Orbitrap Q Exactive HF mass spectrometer. For the cross-linking analysis C7 gel band was cut from a BN-PAGE and cross-linked in-gel. The cross-linked protein were digested in the gel and data was acquired using an Ultimate 3000 system coupled on-line to an Orbitrap Exploris. The raw native MS spectra were deconvoluted to zero-charge spectra by Intact Mass software (Protein Metrics, CA, USA). The spectra were annotated using an in-house developed R script for semi-automated peak annotation, as described previously. The glycopeptide-centric bottom-up raw data were processed by the software Byonic and Skyline. Cross-linking raw data was searched in Proteome discoverer using the XlinkX node. [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Glycosylation ; Cross-linking MS ; Native MS

Contact

Principal Investigators:
(in alphabetical order)
Albert J.R. Heck, Biomolecular Mass Spectrometry and Proteomics groups, Utrecht University, N/A
Submitting User: M_Lukassen
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.